The Testaments out now
Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics - Workshop Summary (Hardback)
  • Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics - Workshop Summary (Hardback)
zoom

Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics - Workshop Summary (Hardback)

(author), (author), (editor), (editor)
£56.00
Hardback 112 Pages / Published: 18/10/2006
  • Not available

This product is currently unavailable.

  • This item has been added to your basket
Research has long sought to identify biomarkers that could detect cancer at an early stage, or predict the optimal cancer therapy for specific patients. Fueling interest in this research are recent technological advances in genomics, proteomics, and metabolomics that can enable researchers to capture the molecular fingerprints of specific cancers and fine-tune their classification according to the molecular defects they harbor. The discovery and development of new markers of cancer could potentially improve cancer screening, diagnosis, and treatment. Given the potential impact cancer biomarkers could have on the cost effectiveness of cancer detection and treatment, they could profoundly alter the economic burden of cancer as well. Despite the promise of cancer biomarkers, few biomarker-based cancer tests have entered the market, and the translation of research findings on cancer biomarkers into clinically useful tests seems to be lagging. This is perhaps not surprising given the technical, financial, regulatory, and social challenges linked to the discovery, development, validation, and incorporation of biomarker tests into clinical practice. To explore those challenges and ways to overcome them, the National Cancer Policy Forum held the conference "Developing Biomarker-Based Tools for Cancer Screening, Diagnosis and Treatment: The State of the Science, Evaluation, Implementation, and Economics" in Washington, D.C., from March 20 to 22, 2006. At this conference, experts gave presentations in one of six sessions. In addition, seven small group discussions explored the policy implications surrounding biomarker development and adoption into clinical practice. Developing Biomarker-based Tools for Developing Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics-Workshop Summary presents the conference proceedings and will be used by an Institute of Medicine (IOM) committee to develop consensus-based recommendations for moving the field of cancer biomarkers forward.

Publisher: National Academies Press
ISBN: 9780309384469
Number of pages: 112
Dimensions: 229 x 152 mm

You may also be interested in...

B is for Breast Cancer
Added to basket
How Football Saved My Life
Added to basket
Radical Remission
Added to basket
Life, Cancer & God
Added to basket
£16.99
Paperback
A World without Cancer
Added to basket
Oxford Handbook of Clinical Haematology
Added to basket
£36.99
Part-work (fascículo)
Lecture Notes: Oncology
Added to basket
Oxford Handbook of Oncology
Added to basket
£36.99
Part-work (fascículo)
Physics for Clinical Oncology
Added to basket
Beat Cancer
Added to basket
£14.99
Paperback
Cancer: A Very Short Introduction
Added to basket
The Emperor of All Maladies
Added to basket
When I Die
Added to basket
£8.99
Paperback
Added Time
Added to basket
£6.99
Paperback
Cancer Virus
Added to basket

Please sign in to write a review

Your review has been submitted successfully.